Screener
Axogen AXGN Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Axogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000805928-26-000094
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 48,606 | 92,840 |
| Commitments and contingencies - see Note 14 | ||
| Shareholders’ equity | ||
| Common stock, $0.01 par value per share; 100,000,000 shares authorized; 53,656,293 and 47,199,797 shares issued and outstanding, respectively | 537 | 472 |
| Additional paid-in capital | 583,783 | 435,338 |
| Accumulated deficit | (328,063) | (306,963) |
| Total shareholders’ equity | 256,257 | 128,847 |
| Total liabilities and shareholders’ equity | $304,863 | $221,687 |
ITEM 1 — FINANCIAL STATEMENTS
FAQ
- What is Axogen's total equity?
- Axogen (AXGN) reported total equity of $256.26M in Q2 2026.
- How has Axogen's total equity changed year-over-year?
- Axogen's total equity increased by 128.2% year-over-year, from $112.28M to $256.26M.
- What is the long-term trend for Axogen's total equity?
- Over 5 years (2020 to 2025), Axogen's total equity has grown at a 0.9% compound annual growth rate (CAGR), from $123.15M to $128.85M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Axogen's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude